Global Artificial Blood Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2016 – 2025

Global Artificial Blood Market, Global Scenario, Market Size, Outlook, Trend, and Forecast, 2016 – 2025

Report Description

Global Artificial Blood Market is expected to reach $10.7 billion by 2025. The expected growth rate is 20.3% from 2017 to 2025. The report highlights the key trends, market outlook and the global scenario of the Global Artificial Blood Market. The market sizing is provided from 2017 to 2025, wherein the forecast is provided from 2017 to 2025. In addition, market dynamics (i.e. market drivers, market restraints and market opportunities) which covers factors supporting the market growth, factors restraining the market growth and factors behind the opportunities across this industry in the coming years has been included extensively under the scope of the study. The report also provides extensive detail of the market segments across type, application, and geography; market share of the key players globally and the competitive scenario throughout the forecast period, industry expert opinion, and profiles of the key players in the market. The major key players of the market are as follows:

KEY PLAYERS

ALLIANCE PHARMACEUTICAL CORP

BAXTER HEALTHCARE CORP.

BIOPURE CORP.

FLUORO2 THERAPEUTICS,INC.

HEMOBIOTECH, INC.

NORTHFIELD LABORATORIES INC.

NUVOX PHARMA LLC.

PROLONG PHARMACEUTICALS, LLC

SANGART, INC.

SANGUINE BIOSCIENCES

TENAX THERAPEUTICS INC.

THERAPURE BIOPHARMA INC.

Scope of the Market

Source Market

Artificial Blood Developed From Human Blood

Artificial Blood Developed From Animal Blood

Artificial Blood Developed Using Recombinant Technology

Type Market

Perfluorocarbon Emulsions

Hemoglobin Based Oxygen CarriersDiabetes

Application Market

Global Potential Artificial Blood Market

Geography Market

North America

Europe

Asia Pacific

Rest of the World (RoW)